VDL meeting

The request was partially successful.

Dear Secretariat General of the European Commission,

Under the right of access to documents in the EU treaties, as developed in Regulation 1049/2001, I am requesting documents which contain the following information:

Any internal notes, memos and correspondence related to Commission President Ursula von der Leyen's January 31, 2021 videoconference with AstraZeneca PLC, BioNTech SE, CureVac AG, SANOFI, Johnson & Johnson (J&J), Pfizer Inc. (PFE) and Moderna Inc.

Yours faithfully,

Lili Bayer
POLITICO Europe
Rue de la Loi 62
Brussels 1040
Belgium

ve_sg.accessdoc (SG), Secretariat General of the European Commission

1 Attachment

Link: [1]File-List
Link: [2]Edit-Time-Data
Link: [3]themeData
Link: [4]colorSchemeMapping

[5]Your access to documents request - VDL meeting - Ref. GESTDEM 2021/3098
- Ares(2021)3157291

Sent by ve_sg.accessdoc (SG) <[SG request email]>. All responses have
to be sent to this email address.
Envoyé par ve_sg.accessdoc (SG) <[SG request email]>. Toutes les
réponses doivent être effectuées à cette adresse électronique.

Dear Madam,

 

Thank you for your e-mail of 11 May 2021. We hereby acknowledge receipt of
your application for access to documents, which was registered on
11/05/2021 under reference number GESTDEM 2021/3098.

 

In accordance with Regulation (EC) No 1049/2001 regarding public access to
European Parliament, Council and Commission documents, your application
will be handled within 15 working days.

 

The time limit will expire on 4 June 2021. In case this time limit needs
to be extended, you will be informed in due course.

 

You have lodged your application via a private third-party website, which
has no link with any institution of the European Union.

Therefore, the European Commission cannot be held accountable for any
technical issues or problems linked to the use of this system.

 

Please note that the private third party running the AsktheEU.org website
is responsible and accountable for the processing of your personal data
via that website, and not the Commission.

For further information on your rights, please refer to the third party’s
privacy policy.

 

We understand that the third party running the AsktheEU.org website
usually publishes the content of applicants’ correspondence with the
Commission on that website. This includes the personal data that you may
have communicated to the Commission (e.g. your private postal address).

 

Similarly, the third party publishes on that website any reply that the
Commission will send to the email address of the applicants generated by
the AsktheEU.org website.

 

If you do not wish that your correspondence with the Commission is
published on a private third-party website such as AsktheEU.org, you can
provide us with an alternative, private e-mail address for further
correspondence. In that case, the Commission will send all future
electronic correspondence addressed to you only to that private address,
and it will use only that private address to reply to your request. You
should still remain responsible to inform the private third-party website
about this change of how you wish to communicate with, and receive a reply
from, the Commission.

 

For information on how we process your personal data visit our page
[6]Privacy statement - access to documents.

 

Yours faithfully,

 

 

 

ACCESS TO DOCUMENTS TEAM (IC)

European Commission

Secretariat-General

SG.C1

[email address]

 

[7]cid:image001.gif@01D46531.06A8B6B0

 

 

 

 

 

show quoted sections

SG UNITE E-4, Secretariat General of the European Commission

2 Attachments